BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11990854)

  • 1. Multiple myeloma: evolving genetic events and host interactions.
    Kuehl WM; Bergsagel PL
    Nat Rev Cancer; 2002 Mar; 2(3):175-87. PubMed ID: 11990854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin and formation of chromosomal translocations in multiple myeloma].
    Nemec P; Kuglík P; Hájek R
    Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 1 abnormalities in multiple myeloma.
    Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosomal translocation and neoplastic transformation].
    Gołos B
    Postepy Biochem; 1985; 31(3-4):601-15. PubMed ID: 3939501
    [No Abstract]   [Full Text] [Related]  

  • 5. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
    Maxwell CA; Pilarski LM
    Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of multiple myeloma.
    Higgins MJ; Fonseca R
    Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal and genetic abnormalities in myeloma.
    Joy Ho P
    Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetics and molecular cytogenetics in multiple myeloma.
    Liebisch P; Döhner H
    Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular pathogenesis of multiple myeloma].
    Iida S
    Rinsho Ketsueki; 2006 Mar; 47(3):196-203. PubMed ID: 16629484
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology and treatment of multiple myeloma.
    Tosi P; Gamberi B; Giuliani N
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):81-6. PubMed ID: 16399590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myeloma.
    Tajima E; Uranishi M; Iida S; Komatsu H; Nitta M; Ueda R
    Haematologica; 2005 Apr; 90(4):559-62. PubMed ID: 15820958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
    Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
    Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26).
    Akalin I; Kutlay NY; Ilhan O; Tukun A
    Int J Lab Hematol; 2007 Jun; 29(3):215-20. PubMed ID: 17474900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis and a consequent classification of multiple myeloma.
    Bergsagel PL; Kuehl WM
    J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
    Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
    Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapies for multiple myeloma.
    Tariman JD
    J Infus Nurs; 2007; 30(2):113-8; quiz 121. PubMed ID: 17413496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.